BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34842457)

  • 1. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
    Zhang Z; Mei Y; Hou M
    Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanism of RNA binding motif protein 15-mediated N
    Chen J
    Environ Toxicol; 2023 Nov; 38(11):2545-2559. PubMed ID: 37471637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
    Wang H; Li C; Wei Q; Zhang E; Yang Y; Sha L; Wang D
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38429603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
    Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
    Transl Oncol; 2024 Jun; 46():102018. PubMed ID: 38838436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.
    Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X
    Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
    Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM15-Mediated m6A Modification of K17 Affects Keratinocytes Response to IL-17A Stimulation in Psoriasis.
    Fu M; Zhou B; Shi N; Dong R; Chen Y
    Ann Clin Lab Sci; 2023 Jul; 53(4):529-538. PubMed ID: 37625827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
    Wang R; Tan W
    Crit Rev Eukaryot Gene Expr; 2024; 34(5):15-29. PubMed ID: 38842201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M6A methylation of DEGS2, a key ceramide-synthesizing enzyme, is involved in colorectal cancer progression through ceramide synthesis.
    Guo W; Zhang C; Feng P; Li M; Wang X; Xia Y; Chen D; Li J
    Oncogene; 2021 Oct; 40(40):5913-5924. PubMed ID: 34363020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
    Dai X; Chen K; Xie Y
    Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
    Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
    Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.